The PE ratio for Dixie Finance currently sits at 14.8, below the sector median of 16.2, giving value investors a potential entry point before the next dividend announcement, expected in late August. After a hiatus on its repayment of the $1 million loan from the city, Dixie Carter's father, Robert, the Panda Biotech chairman and CEO, personally guaranteed repaying of the note at a rate of $70,000 a month. Dixie Carter said the loan, with interest, will be paid off in December. For the fiscal year 2024, net sales for the Company were $265,026,000 as compared to $276,343,000 for the fiscal year 2023. The net loss from continuing operations on the year was $12,210,000 in 2024, or $0.83 per diluted share, compared to a net loss of $1,952,000, or $0.13 per diluted share, in 2023. The net loss on the year was $13,000,000, or $0.88 per diluted share, compared to a net loss of $2,718,000, or $.18 per diluted share, in 2023. Short interest in Dixie Finance dropped from 4.3% to 3.7% in two weeks, reflecting a shift in sentiment among bearish traders. Historical data suggests such moves often precede moderate price rallies.